Clinical Trial Update: Safety and Efficacy of Canagliflozin in Patients With Metastatic High Microsatellite Instability (MSI-H) Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the safety and efficacy of canagliflozin in patients with metastatic MSI-H colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Canagliflozin (canagliflozin)

Snippet

Sponsor: West China Hospital | Conditions: Colorectal Cancer, SGLT-2 Inhibitor | Phase 1 | Status: RECRUITING